Pharmaceutical companies qualified to manufacture either active substances or medicines will now be able to produce cannabis-based medicines in France.
Developing a French “patient to seed” ecosystem to improve the therapeutic benefit of medical Cannabis
“Simply replacing the imported products currently specified for the pilot program with French-produced equivalents would be a missed opportunity and a disservice to patients”
Nanosizing drug particles brings key benefits for oral formulations of poorly soluble drugs such as Biopharmaceutics Classification System (BCS) Class II drugs.
SEPAREX, the gold standard in supercritical fluids, was founded in 1985 by Michel Perrut.
SEPAREX was also a pioneering business incubator, far ahead of its time, contributing to the birth of 8 companies.